National Bank of Canada’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331 | Sell |
106
-3,127
| -97% | -$9.77K | ﹤0.01% | 2432 |
|
|
2025
Q1 | $7.15K | Sell |
3,233
-71,668
| -96% | -$158K | ﹤0.01% | 1988 |
|
|
2024
Q4 | $219K | Buy |
74,901
+9,804
| +15% | +$28.7K | ﹤0.01% | 1267 |
|
|
2024
Q3 | $169K | Buy |
65,097
+26,002
| +67% | +$67.6K | ﹤0.01% | 1248 |
|
|
2024
Q2 | $109K | Sell |
39,095
-144,790
| -79% | -$402K | ﹤0.01% | 1327 |
|
|
2024
Q1 | $704K | Buy |
183,885
+176,200
| +2,293% | +$675K | ﹤0.01% | 1037 |
|
|
2023
Q4 | $44K | Buy |
7,685
+1,600
| +26% | +$9.16K | ﹤0.01% | 1643 |
|
|
2023
Q3 | $27K | Buy |
6,085
+4,850
| +393% | +$21.5K | ﹤0.01% | 1749 |
|
|
2023
Q2 | $7.97K | Hold |
1,235
| – | – | ﹤0.01% | 2069 |
|
|
2023
Q1 | $9.31K | Buy |
1,235
+35
| +3% | +$264 | ﹤0.01% | 2018 |
|
|
2022
Q4 | $12.1K | Sell |
1,200
-1,500
| -56% | -$15.2K | ﹤0.01% | 1963 |
|
|
2022
Q3 | $27K | Buy |
2,700
+1,105
| +69% | +$11.1K | ﹤0.01% | 1752 |
|
|
2022
Q2 | $17K | Buy |
1,595
+150
| +10% | +$1.6K | ﹤0.01% | 1910 |
|
|
2022
Q1 | $14K | Buy |
1,445
+300
| +26% | +$2.91K | ﹤0.01% | 2034 |
|
|
2021
Q4 | $16K | Buy |
+1,145
| New | +$16K | ﹤0.01% | 1988 |
|